Fidelity National Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-290,290
| Closed | -$45M | – | 25 |
|
|
2023
Q4 | $45M | Hold |
290,290
| – | – | 0.81% | 6 |
|
|
2023
Q3 | $43.3M | Hold |
290,290
| – | – | 1.19% | 6 |
|
|
2023
Q2 | $39.1M | Hold |
290,290
| – | – | 1.19% | 5 |
|
|
2023
Q1 | $46.3M | Hold |
290,290
| – | – | 1.77% | 6 |
|
|
2022
Q4 | $46.9M | Hold |
290,290
| – | – | 1.7% | 6 |
|
|
2022
Q3 | $39M | Hold |
290,290
| – | – | 5.97% | 6 |
|
|
2022
Q2 | $44.5M | Hold |
290,290
| – | – | 6.35% | 6 |
|
|
2022
Q1 | $47.1M | Hold |
290,290
| – | – | 4.69% | 7 |
|
|
2021
Q4 | $39.3M | Hold |
290,290
| – | – | 3.26% | 7 |
|
|
2021
Q3 | $31.3M | Hold |
290,290
| – | – | 2.33% | 7 |
|
|
2021
Q2 | $32.7M | Hold |
290,290
| – | – | 2.37% | 6 |
|
|
2021
Q1 | $31.4M | Hold |
290,290
| – | – | 2.26% | 7 |
|
|
2020
Q4 | $31.1M | Hold |
290,290
| – | – | 3.93% | 6 |
|
|
2020
Q3 | $25.4M | Hold |
290,290
| – | – | 3.7% | 7 |
|
|
2020
Q2 | $28.5M | Hold |
290,290
| – | – | 4.07% | 6 |
|
|
2020
Q1 | $22.1M | Hold |
290,290
| – | – | 3.52% | 7 |
|
|
2019
Q4 | $25.7M | Hold |
290,290
| – | – | 3.17% | 6 |
|
|
2019
Q3 | $22M | Hold |
290,290
| – | – | 3.22% | 8 |
|
|
2019
Q2 | $21.1M | Buy |
290,290
+82,340
| +40% | +$6.47M | 3.06% | 8 |
|
|
2019
Q1 | $16.8M | Hold |
207,950
| – | – | 2.65% | 11 |
|
|
2018
Q4 | $19.2M | Hold |
207,950
| – | – | 3.85% | 8 |
|
|
2018
Q3 | $19.7M | Hold |
207,950
| – | – | 2.88% | 9 |
|
|
2018
Q2 | $19.3M | Hold |
207,950
| – | – | 2.88% | 9 |
|
|
2018
Q1 | $19.7M | Hold |
207,950
| – | – | 2.91% | 9 |
|
|
2017
Q4 | $20.1M | Hold |
207,950
| – | – | 2.96% | 9 |
|
|
2017
Q3 | $18.5M | Hold |
207,950
| – | – | 4.05% | 9 |
|
|
2017
Q2 | $15.1M | Hold |
207,950
| – | – | 3.44% | 10 |
|
|
2017
Q1 | $13.6M | Hold |
207,950
| – | – | 3.18% | 10 |
|
|
2016
Q4 | $13M | Hold |
207,950
| – | – | 2.98% | 12 |
|
|
2016
Q3 | $13.1M | Hold |
207,950
| – | – | 3.03% | 11 |
|
|
2016
Q2 | $12.9M | Hold |
207,950
| – | – | 3.34% | 11 |
|
|
2016
Q1 | $11.9M | Hold |
207,950
| – | – | 3.78% | 9 |
|
|
2015
Q4 | $12.3M | Hold |
207,950
| – | – | 4.13% | 9 |
|
|
2015
Q3 | $11.3M | Buy |
207,950
+100,500
| +94% | +$6.54M | 3.62% | 11 |
|
|
2015
Q2 | $7.22M | Hold |
107,450
| – | – | 2.6% | 14 |
|
|
2015
Q1 | $6.29M | Buy |
+107,450
| New | +$6.49M | 3.16% | 5 |
|
Other funds holding ABBV
Fidelity National Financial's ABBV Position: Q1 2024 in Review
Fidelity National Financial sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 290,290 shares — an estimated $45M sold.
Fidelity National Financial first reported a position in ABBV in Q1 2015 and held it in 36 quarters. The position peaked at $47.1M in Q1 2022. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.
- Fidelity National Financial reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
- Fidelity National Financial sold 290,290 AbbVie shares in Q1 2024, an estimated $45M.
- Fidelity National Financial first reported a position in AbbVie in Q1 2015 and held it in 36 quarters.
- Fidelity National Financial's AbbVie position peaked at $47.1M in Q1 2022.
- 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.
Based on Fidelity National Financial's 13F filing for Q1 2024, filed 9 May 2024.